MEDTRONIC PLC. overview

Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients PR Newswire GALWAY, Ireland and CHICAGO, March 30, 2025 GALWAY , Ireland and CHICAGO , March 30, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ transcatheter aortic valve...

SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients PR Newswire GALWAY, Ireland and WASHINGTON, March 9, 2025 CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON , March 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT ), a global leader in healthcare technology, today...

Medtronic announces cash dividend for fourth quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, March 6, 2025 GALWAY , Ireland , March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal year 2025 of $0 .70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic is a constituent of...

Medtronic Malaysia and Malaysian Society of Colorectal Surgeons sign MOU to enhance medical training and education programs PR Newswire KUALA LUMPUR, Malaysia, Feb. 25, 2025 KUALA LUMPUR, Malaysia , Feb. 25, 2025 /PRNewswire/ -- Medtronic plc, a global leader in healthcare technology, announced that Medtronic Malaysia and Malaysian Society of Colorectal Surgeons (MSCRS) have signed a Memorandum of Understanding (MoU) to jointly organize surgical workshops aimed at enhancing the skills of...

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's PR Newswire GALWAY, Ireland, Feb. 24, 2025 New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland , Feb. 24, 2025 /PRNewswire/ -- For the one million people diagnosed with Parkinson's disease in the United States 1 , Medtronic plc (NYSE:MDT), a global...

Medtronic reports third quarter fiscal 2025 financial results PR Newswire GALWAY, Ireland, Feb. 18, 2025 Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland , Feb. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025 . Key Highlights Revenue of $8.3 billion increased...

Medtronic reports third quarter fiscal 2025 financial results PR Newswire GALWAY, Ireland, Feb. 18, 2025 Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland , Feb. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025 . Key Highlights Revenue of $8.3 billion increased...

Medtronic to announce financial results for its third quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, Feb. 6, 2025 GALWAY , Ireland , Feb. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025 . A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at...